Sequential involvement of two distinct CD4+ regulatory T cells during the course of transplantable tumor growth and protection from 3-methylcholanthrene-induced tumorigenesis by CD25-depletion

Japanese Journal of Cancer Research

Volumn 93, Issue 8, 2002, Pages 911-916

  Tawara, Isao ^a   Take, Yutaka ^a   Uenaka, Akiko ^a   Noguchi, Yuji ^a   Nakayama, Eiichi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Chemical carcinogenesis; CTL; Regulatory T cells; Tumor growth

Indexed keywords

3 METHYLCHOLANTHRENE; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY GK1.5; MONOCLONAL ANTIBODY PC61; UNCLASSIFIED DRUG; CARCINOGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CANCER TRANSPLANTATION; CARCINOGENESIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; FIBROSARCOMA; INOCULATION; LEUKEMIA; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH; TUMOR REJECTION; ANIMAL; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIVISION; CHEMICALLY INDUCED DISORDER; FLOW CYTOMETRY; MALE; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; RADIATION INJURY; TIME;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOGENS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DOWN-REGULATION; FLOW CYTOMETRY; MALE; METHYLCHOLANTHRENE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0036670289     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01337.x     Document Type: Article

References (23)

1. Regulatory T cells: Key controllers of immunologic self-tolerance
2. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune disease
3. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
4. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells
5. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
6. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
7. + T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation
8. Administration of anti-interleukin-2 receptor α antibody in vivo induces localized autoimmune disease
9. + immunoregulatory T cells that control autoimmune diabetes
10. + suppressor T cells
11. Expression of multiple unique rejection antigens on murine leukemia BALB/c RL male 1 and the role of dominant Akt antigen for tumor escape
12. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody
13. Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity
14. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: Description of a unique antigen on BALB/c Meth A sarcoma
15. - antigen with a cytolytic T cell stimulation assay
16. High and low affinity IL-2 receptors: Analysis by IL-2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61
17. Characterization of the murine T cell surface molecule, designated L3T4 identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule
18. Identification of a unique antigen peptide pRL1 on BALB/c RL♂ 1 leukemia recognized by cytotoxic T-lymphocytes and its relation to the Akt oncogene
19. Rejection antigen peptides on BALB /c RL♂ 1 leukemia recognized by cytotoxic T lymphocytes: Derivation from the normally untranslated 5′-region of the c-akt proto-oncogene activated by LTR
20. + effector T cells
21. + immunoregulatory T cells is antigen nonspecific
22. - subpopulations
23. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity